17032

    539871

    THYROCARE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    THYROCARE TECH LTD Share Price Today

    THYROCARE TECH LTD is currently trading at ₹520.6, down by ₹6.65 from the previous close. The stock touched an intraday high of ₹531.15 and a low of ₹514.10 during the latest trading session. Over the past one year, THYROCARE TECH LTD has delivered a return of 31.99%, while the stock has declined 1.19% in the last one month.

    THYROCARE TECH LTD performance

    Today’s low Today’s high
    ₹ 514.10 ₹ 531.15
    ₹ 520.60
    52 week low 52 week high
    ₹ 342.55 ₹ 578.25
    ₹ 520.60
    Open Price ₹ 527.25
    Prev. Close ₹ 527.25
    Volume (Shares) 222139.00
    Total traded value ₹ 1156.45
    Upper Circuit ₹ 632.70
    Lower Circuit ₹ 421.80
    info

    Investment Returns

    Over 1 Month -1.19% Over 3 Months 33.70% Over 6 Months 12.91% Over 1 Year 31.99%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    THYROCARE TECH LTD fundamentals


    • Market cap (Cr) 8,286.10
    • P/E Ratio (TTM) 56.41
    • Beta 0.54
    • Book Value / share 30.79
    • Return on equity 27.11%
    • EPS (TTM) 9.24
    • Dividend yield 2.65%
    • Net profit/quarter (Cr) 43.58
    info icon alternate text
    • Market cap (Cr) 8,279.80
    • P/E Ratio (TTM) 56.41
    • Beta 0.49
    • Book Value / share 30.79
    • Return on equity 27.11%
    • EPS (TTM) 9.24
    • Dividend yield 2.65%
    • Net profit/quarter (Cr) 43.58
    info icon alternate text

    THYROCARE TECH LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 210.67
    Operating Expense 152.41
    Net Profit 43.58
    Net Profit Margin (%) 20.68
    Earnings Per Share (EPS) 2.75
    EBITDA 76.35
    Effective Tax Rate (%) 29.68
    Particulars DEC 2025 (Values in Cr)
    Revenue 182.48
    Operating Expense 143.32
    Net Profit 26.15
    Net Profit Margin (%) 14.33
    Earnings Per Share (EPS) 1.64
    EBITDA 55.73
    Effective Tax Rate (%) 28.59
    Particulars SEP 2025 (Values in Cr)
    Revenue 202.23
    Operating Expense 143.62
    Net Profit 43.03
    Net Profit Margin (%) 21.27
    Earnings Per Share (EPS) 8.12
    EBITDA 71.19
    Effective Tax Rate (%) 29.33
    Particulars JUN 2025 (Values in Cr)
    Revenue 178.89
    Operating Expense 131.94
    Net Profit 36.05
    Net Profit Margin (%) 20.15
    Earnings Per Share (EPS) 6.80
    EBITDA 60.47
    Effective Tax Rate (%) 29.18
    Particulars MAR 2025 (Values in Cr)
    Revenue 173.87
    Operating Expense 130.60
    Net Profit 21.95
    Net Profit Margin (%) 12.62
    Earnings Per Share (EPS) 4.08
    EBITDA 60.18
    Effective Tax Rate (%) 54.07
    Particulars MAR 2026 (Values in Cr)
    Revenue 774.27
    Operating Expense 571.29
    Net Profit 148.81
    Net Profit Margin (%) 19.21
    Earnings Per Share (EPS) 9.36
    EBITDA 263.75
    Effective Tax Rate (%) 29.27
    Particulars MAR 2025 (Values in Cr)
    Revenue 633.10
    Operating Expense 495.23
    Net Profit 95.78
    Net Profit Margin (%) 15.12
    Earnings Per Share (EPS) 17.95
    EBITDA 200.36
    Effective Tax Rate (%) 36.65
    Particulars MAR 2024 (Values in Cr)
    Revenue 524.02
    Operating Expense 432.98
    Net Profit 71.14
    Net Profit Margin (%) 13.57
    Earnings Per Share (EPS) 13.44
    EBITDA 141.06
    Effective Tax Rate (%) 27.57
    Particulars MAR 2023 (Values in Cr)
    Revenue 486.46
    Operating Expense 410.78
    Net Profit 56.97
    Net Profit Margin (%) 11.71
    Earnings Per Share (EPS) 10.77
    EBITDA 117.39
    Effective Tax Rate (%) 29.72
    Particulars MAR 2022 (Values in Cr)
    Revenue 561.53
    Operating Expense 361.55
    Net Profit 152.05
    Net Profit Margin (%) 27.07
    Earnings Per Share (EPS) 28.75
    EBITDA 238.23
    Effective Tax Rate (%) 26.68
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 32.21
    ROE % 28.77
    ROCE % 35.35
    Total Debt to Total Equity 0.07
    EBITDA Margin 33.22
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 92.81
    ROE % 16.91
    ROCE % 25.93
    Total Debt to Total Equity 0.06
    EBITDA Margin 29.74
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 93.03
    ROE % 13.10
    ROCE % 17.92
    Total Debt to Total Equity 0.06
    EBITDA Margin 25.97
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 97.37
    ROE % 12.13
    ROCE % 16.86
    Total Debt to Total Equity 0.04
    EBITDA Margin 25.09
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 99.54
    ROE % 33.05
    ROCE % 41.39
    Total Debt to Total Equity 0.03
    EBITDA Margin 40.79
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 30.79
    ROE % 27.11
    ROCE % 35.67
    Total Debt to Total Equity 0.07
    EBITDA Margin 34.19
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 91.19
    ROE % 18.23
    ROCE % 27.26
    Total Debt to Total Equity 0.06
    EBITDA Margin 31.73
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 90.58
    ROE % 13.75
    ROCE % 18.63
    Total Debt to Total Equity 0.06
    EBITDA Margin 27.14
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 94.86
    ROE % 10.94
    ROCE % 15.73
    Total Debt to Total Equity 0.04
    EBITDA Margin 24.60
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 98.43
    ROE % 31.48
    ROCE % 41.64
    Total Debt to Total Equity 0.03
    EBITDA Margin 42.55
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 68.16
    Total Assets 747.22
    Total Liabilities 747.22
    Total Equity 586.02
    Share Outstanding 15
    Price to Book Ratio 11.36
    Return on Assets (%) 21.81
    Return on Capital (%) 27.82
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 54.48
    Total Assets 692.75
    Total Liabilities 692.75
    Total Equity 547.05
    Share Outstanding 5
    Price to Book Ratio 7.46
    Return on Assets (%) 13.20
    Return on Capital (%) 16.73
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 39.89
    Total Assets 643.88
    Total Liabilities 643.88
    Total Equity 527.63
    Share Outstanding 5
    Price to Book Ratio 6.54
    Return on Assets (%) 10.98
    Return on Capital (%) 12.88
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 28.47
    Total Assets 632.72
    Total Liabilities 632.72
    Total Equity 535.22
    Share Outstanding 5
    Price to Book Ratio 4.53
    Return on Assets (%) 10.19
    Return on Capital (%) 12.05
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 13.91
    Total Assets 607.66
    Total Liabilities 607.66
    Total Equity 526.57
    Share Outstanding 5
    Price to Book Ratio 7.86
    Return on Assets (%) 28.98
    Return on Capital (%) 33.45
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 62.63
    Total Assets 711.21
    Total Liabilities 711.21
    Total Equity 560.68
    Share Outstanding 15
    Price to Book Ratio 11.36
    Return on Assets (%) 20.92
    Return on Capital (%) 26.54
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 51.98
    Total Assets 676.35
    Total Liabilities 676.35
    Total Equity 537.10
    Share Outstanding 5
    Price to Book Ratio 7.46
    Return on Assets (%) 14.16
    Return on Capital (%) 17.83
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 34.10
    Total Assets 620.27
    Total Liabilities 620.27
    Total Equity 513.81
    Share Outstanding 5
    Price to Book Ratio 6.54
    Return on Assets (%) 11.46
    Return on Capital (%) 13.33
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 16.39
    Total Assets 611.87
    Total Liabilities 611.87
    Total Equity 521.04
    Share Outstanding 5
    Price to Book Ratio 4.53
    Return on Assets (%) 9.31
    Return on Capital (%) 10.93
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 12.00
    Total Assets 597.17
    Total Liabilities 597.17
    Total Equity 520.70
    Share Outstanding 5
    Price to Book Ratio 7.86
    Return on Assets (%) 25.46
    Return on Capital (%) 29.2
    Particulars MAR 2026 (Values in Cr)
    Net Income 212.88
    Cash from Operations 273.05
    Cash from Investing -23.00
    Cash from Financing -169.59
    Net change in Cash 20.64
    Free Cash Flow 293.93
    Particulars MAR 2025 (Values in Cr)
    Net Income 146.88
    Cash from Operations 232.70
    Cash from Investing -52.52
    Cash from Financing -130.42
    Net change in Cash 8.38
    Free Cash Flow 277.59
    Particulars MAR 2024 (Values in Cr)
    Net Income 95.59
    Cash from Operations 196.62
    Cash from Investing -91.29
    Cash from Financing -84.81
    Net change in Cash -8.47
    Free Cash Flow 258.20
    Particulars MAR 2023 (Values in Cr)
    Net Income 87.41
    Cash from Operations 157.77
    Cash from Investing -38.99
    Cash from Financing -86.18
    Net change in Cash 4.14
    Free Cash Flow 201.42
    Particulars MAR 2022 (Values in Cr)
    Net Income 227.90
    Cash from Operations 170.17
    Cash from Investing -23.57
    Cash from Financing -89.41
    Net change in Cash 0.43
    Free Cash Flow 208.00
    Particulars MAR 2026 (Values in Cr)
    Net Income 210.40
    Cash from Operations 266.35
    Cash from Investing -20.92
    Cash from Financing -167.44
    Net change in Cash 17.70
    Free Cash Flow 285.28
    Particulars MAR 2025 (Values in Cr)
    Net Income 151.21
    Cash from Operations 227.64
    Cash from Investing -42.58
    Cash from Financing -124.44
    Net change in Cash 11.62
    Free Cash Flow 262.46
    Particulars MAR 2024 (Values in Cr)
    Net Income 98.22
    Cash from Operations 184.18
    Cash from Investing -80.29
    Cash from Financing -83.71
    Net change in Cash -8.81
    Free Cash Flow 227.45
    Particulars MAR 2023 (Values in Cr)
    Net Income 81.07
    Cash from Operations 148.72
    Cash from Investing -31.65
    Cash from Financing -87.50
    Net change in Cash 0.87
    Free Cash Flow 169.84
    Particulars MAR 2022 (Values in Cr)
    Net Income 207.38
    Cash from Operations 162.00
    Cash from Investing -12.32
    Cash from Financing -86.91
    Net change in Cash 6.45
    Free Cash Flow 202.41
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8886.25 65.32 13.48 127770.64 6680.00 9008.90
    FORTIS MALAR HOSPITALS LIMITED 50.05 22.65 2.73 93.80 40.75 76.00
    SHREE PACETRONIX LTD. 143.20 17.09 3.01 53.70 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.07 0.00 2.77 23.26 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8886.25 85.11 12.82 127770.64 6680.00 9008.90
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 37.61 0.00 -9.15 28.09 30.30 57.48
    KOVAI MEDICAL CENTER & HOSPITA 5952.90 26.64 4.93 6512.47 5010.00 6725.00

    THYROCARE TECH LTD shareholding pattern

    Holding
    12.71%
    60.92%
    5.43%
    20.92%
    100.0%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    THYROCARE TECH LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    520.60 -1.26 redarrow
    red-green-graph indicator
    10 Bearish
    6 Bullish
    • 5 Days 528.50
    • 26 Days 527.80
    • 10 Days 530.60
    • 50 Days 508.30
    • 12 Days 531.20
    • 100 Days 478.00
    • 20 Days 530.70
    • 200 Days 446.10
    529.32 PIVOT
    First Support 520.93 First Resistance 535.63 Second Support 514.62 Second Resistance 544.02 Third Support 506.23 Third Resistance 550.33
    RSI 50.05 ADX 19.97 MACD 3.45 Williams % R -63.45 Commodity Channel Index (CCI) -55.86
    Date 2026-07-16 Week 183280.00 Same Day 151367.00 Month 160052.00
    1 Year 0.55 3 Year 0.49
    Over 1 Month
    -1.19% down
    Over 1 Year
    31.99% down
    Over 3 Months
    33.70% down
    Over 3 Years
    41.62% down
    Over 6 Months
    12.91% down
    Over 5 Years
    3.67% down

    THYROCARE TECH LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Jun 2026 7.0 Final 23 Jun 2026 Equity shares
    24 Oct 2025 7.0 Interim 24 Oct 2025 Equity shares
    25 Jul 2025 21.0 Final 25 Jul 2025 Equity shares
    16 Aug 2024 18.0 Final 16 Aug 2024 Equity shares
    20 Apr 2023 18.0 Interim 20 Apr 2023 Equity shares
    11 May 2022 15.0 Interim 12 May 2022 Equity shares
    17 Jun 2021 15.0 Final 19 Jun 2021 Equity shares
    12 Nov 2020 10.0 Interim 13 Nov 2020 Equity shares
    21 Nov 2019 5.0 Interim 22 Nov 2019 Equity shares
    14 Aug 2019 20.0 Final 18 Aug 2019 Equity shares
    02 Aug 2018 5.0 Final 04 Aug 2018 Equity shares
    15 Feb 2018 5.0 Interim 16 Feb 2018 Equity shares
    03 Aug 2017 5.0 Final 06 Aug 2017 Equity shares
    08 Feb 2017 5.0 Interim 09 Feb 2017 Equity shares
    01 Sep 2016 2.5 Final 05 Sep 2016 Equity shares
    Ex-Date Ex-Bonus Ratio
    28 Nov 2025 28 Nov 2025 2:1
    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Jun 2026 7.0 Final 23 Jun 2026 Equity shares
    24 Oct 2025 7.0 Interim 24 Oct 2025 Equity shares
    25 Jul 2025 21.0 Final 25 Jul 2025 Equity shares
    16 Aug 2024 18.0 Final 16 Aug 2024 Equity shares
    20 Apr 2023 18.0 Interim 20 Apr 2023 Equity shares
    11 May 2022 15.0 Interim 12 May 2022 Equity shares
    17 Jun 2021 15.0 Final 19 Jun 2021 Equity shares
    12 Nov 2020 10.0 Interim 13 Nov 2020 Equity shares
    21 Nov 2019 5.0 Interim 22 Nov 2019 Equity shares
    14 Aug 2019 20.0 Final 18 Aug 2019 Equity shares
    02 Aug 2018 5.0 Final 04 Aug 2018 Equity shares
    15 Feb 2018 5.0 Interim 16 Feb 2018 Equity shares
    03 Aug 2017 5.0 Final 06 Aug 2017 Equity shares
    08 Feb 2017 5.0 Interim 09 Feb 2017 Equity shares
    01 Sep 2016 2.5 Final 05 Sep 2016 Equity shares
    Ex-Date Ex-Bonus Ratio
    28 Nov 2025 28 Nov 2025 2:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Thyrocare Technologies Ltd?

    Answer Field

    Thyrocare Technologies Ltd share price is for NSE ₹ 520.60 & for BSE ₹ 516.65 as on Jul 17 2026 03:30 PM.

    What is the Market Cap of Thyrocare Technologies Ltd Share?

    Answer Field

    The market cap of Thyrocare Technologies Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 17 2026 03:30 PM.

    What is the 52 Week High and Low of Thyrocare Technologies Ltd?

    Answer Field

    The 52 Week High and Low of Thyrocare Technologies Ltd for NSE is ₹ 578.25 and ₹ 342.55 and for BSE is ₹ 578.05 and ₹ 342.55.

    What is 1 year return for Thyrocare Technologies Ltd?

    Answer Field

    The 1 year returns on the stock has been 31.99%.

    What is the P/E Ratio of Thyrocare Technologies Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM the price-to-earnings (PE) ratio for Thyrocare Technologies Ltd share is 56.41.

    What is the PB ratio of Thyrocare Technologies Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM, the price-to-book (PB) ratio for Thyrocare Technologies Ltd share is 30.79.

    How to Buy Thyrocare Technologies Ltd Share?

    Answer Field

    You can trade in Thyrocare Technologies Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Thyrocare Technologies Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Thyrocare Technologies Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Thyrocare Technologies Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |